Chroma Therapeutics
cancer and inflammation treatments
Chroma Therapeutics is a privately-held biotechnology company focused on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. Chroma is the first company to systematically...Homepage: http://www.chromatherapeutics.com/
Total money raised: $77.5M
OX14 4RY
93 Milton Park
Abingdon
Oxon
GBR
Abingdon
Oxon
GBR
Phone: 44-(0)1235-829120
Updated on Apr 30, 2013
Chroma Therapeutics at CrunchBase
Chroma Therapeutics at CrunchBase
June, 2009
Chroma Therapeutics raised $24.5M in unattributed round from Abingworth, Essex Woodlands Health Ventures, Gilde IT Fund, Wellcome Trust, GlaxoSmithKline, and Nomura Securities
April, 2006
Chroma Therapeutics raised $53M in a Series C round from Nomura Phase4 Ventures, Abingworth, Essex Woodlands Health Ventures, Gilde Healthcare Partners, and The Welcom Trust
CHROMA THERAPEUTICS COMPLETES $53 MILLION SERIES C FINANCING 
chromatherapeutics.com